BioAge Labs Raises $170m to Develop Therapies Using AI
February 13, 2024
2,640
51
5
2.12%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Bloomberg Technology Episodes Around February 13, 2024
See what was published immediately before and after this episode.
2:23Now PlayingBioAge Labs Raises $170m to Develop Therapies Using AI
YouTube Description
as posted by the channelBioAge Labs, a clinical-stage biotechnology company developing therapies for obesity and metabolic disease thanks to their AI-powered discovery platform, raised $170 million in an oversubscribed series D financing round led by Sofinnova Investments. Kristen Fortney, BioAge CEO and Co-Founder, joins Ed Ludlow and Caroline Hyde on "Bloomberg Technology."
--------
Like this video? Subscribe to Bloomberg Technology on YouTube:
Watch the latest full episodes of "Bloomberg Technology" with Caroline Hyde and Ed Ludlow here
Get the latest in tech from Silicon Valley and around the world here:
Connect with us on...
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.